SCHEMBL6501925

SCHEMBL6501925

CCOC(=O)c1ccc(-n2nc(-c3c(F)cccc3Cl)nc2C)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.53
TP53 P04637 2/20 0.53
KMT2A Q03164 2/20 0.51
ALDH1A1 P00352 4/20 0.45
POLB P06746 1/20 0.45
RXFP1 Q9HBX9 2/20 0.43
HTT P42858 4/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
NPBWR1 P48145 1/20 0.42
MCHR1 Q99705 1/20 0.42
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TRPV4 Q9HBA0 1/20 0.42
HPGD P15428 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
FGFR1 P11362 1/20 0.41
HSP90AA1 P07900 1/20 0.40
CACNA1B Q00975 1/20 0.40
APBA1 Q02410 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6499919 0.82 KMT2A (0.38) KMT2AALDH1A1HTTNPBWR1SMN1; SMN2
SCHEMBL18255780 0.78 MAPT (0.58) MAPTTP53KMT2AALDH1A1POLB
SCHEMBL16797124 0.74 RORC (0.52) MAPTTP53ALDH1A1POLBRXFP1
SCHEMBL17055295 0.73 MAPT (0.51) MAPTTP53KMT2AALDH1A1HTT
SCHEMBL6506918 0.72 MAPK14 (0.33) KMT2AALDH1A1SMN1; SMN2HPGDLMNA
SCHEMBL18255787 0.71 TTR (0.57) MAPTTP53KMT2AALDH1A1HTT
SCHEMBL9049556 0.70 MAPT (0.43) MAPTTP53KMT2AALDH1A1POLB
SCHEMBL9907336 0.69 ALDH1A1 (0.50) MAPTTP53KMT2AALDH1A1RXFP1
SCHEMBL9907616 0.69 ALDH1A1 (0.55) MAPTTP53ALDH1A1RXFP1HTT
SCHEMBL6638605 0.69 MAPT (0.54) MAPTTP53KMT2AALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050009834-A1 Azole compounds, process for preparation of the same and use thereof SUMITOMO CHEMICAL TAKEDA AGRO COMPANY, LIMITED (JP) 2005-01-13 US disclosed
EP-1386915-A1 AZOLE COMPOUNDS, PROCESS FOR PREPARATION OF THE SAME AND USE THEREOF Sumitomo Chemical Takeda Agro Company, Limited (JP) 2004-02-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009834-A1 Azole compounds, process for preparation of the same and use thereof C1S, CYP4B1, CYP4X1 MAPT 4519/4885TP53 3696/4885KMT2A 1067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.